Tns Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 27-10-2024
- Paid Up Capital ₹ 3.00 Cr
as on 27-10-2024
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.00 Cr
as on 27-10-2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth 2906.54%
(FY 2023)
- Total Assets 6919.87%
(FY 2023)
About Tns Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹19.00 Cr.
Ajitbhai Jagani, Hemantkumar Jagani, and Shravan Patel serve as directors at the Company.
- CIN/LLPIN
U24290GJ2021PTC128263
- Company No.
128263
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2021
- Date of AGM
13 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Tns Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajitbhai Jagani  | Director | 27-Dec-2021 | Current |
| Hemantkumar Jagani | Director | 31-Mar-2023 | Current |
| Shravan Patel | Director | 24-May-2024 | Current |
Financial Performance of Tns Pharma.
Tns Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 2906.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Tns Pharma?
In 2023, Tns Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sarita Poly Tex Private LimitedActive 14 years 5 monthsAjitbhai Jagani and Hemantkumar Jagani are mutual person
- Tricorp Laboratories Private LimitedActive 2 years 6 months
Ajitbhai Jagani and Shravan Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 01 Mar 2023 | ₹9.50 Cr | Open |
Axis Bank Limited Creation Date: 27 Jan 2023 | ₹9.50 Cr | Open |
How Many Employees Work at Tns Pharma?
Unlock and access historical data on people associated with Tns Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tns Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tns Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
